Noncompaction cardiomyopathy genetic testing
Jump to navigation
Jump to search
|
Noncompaction Cardiomyopathy Microchapters |
|
Pathophysiology |
|---|
|
Differentiating Noncompaction Cardiomyopathy from other Diseases |
|
Diagnosis |
|
Treatment |
|
Noncompaction cardiomyopathy genetic testing On the Web |
|
Risk calculators and risk factors for Noncompaction cardiomyopathy genetic testing |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Genetic testing can be of use in counseling family members.
Demographics and Epidemiology
40% of family members will be affected.
Diagnosis
Specific Genes to Test For
Known mutations should be tested for. Examples include the following:
- One defect is in the gene that encodes for alpha-dystrobrevin. This is a dystrophin-associated protein which has been mapped to chromosome 18q12. The role of this protein is to preserve the structural integrity of the muscle membrane.
- There is a second X-linked genetic defect which involves a mutation in the gene G4.5 (TAZ), the same gene involved in Barth syndrome. As a result, some patients with NCC have features of Barth syndrome. This gene which encodes for tafazzin.
- Mutations of the ryanodine receptor 2 gene (RyR2) as has been seen in patients with arrhythmogenic right ventircular dysplasia.
- Deletions of the FKBP12 gene result in noncompaction in the mouse.
- LMNA mutations
- Abnormalities of trnascription factors such as NKX2.5 and TBX5.
- Abnormalities of 11p15 as suggested in a GWAS analysis.
- 22q11 deletion
The majority of the time the pattern of inheritance is autosomal dominant. In some families, the mode of transmission appears to be x-linked or via mitochondrial transmission.